Aerosol formulations of alpha8 tetrahydrocannabinol

Details for Australian Patent Application No. 2002319422 (hide)

Owner Norton Healthcare Limited

Inventors Langford, Alan; Woolfe, Austen John

Agent Griffith Hack

Pub. Number AU-B-2002319422

PCT Number PCT/GB02/03161

PCT Pub. Number WO2003/006010

Priority 60/305,021 10.07.01 US

Filing date 10 July 2002

Wipo publication date 29 January 2003

Acceptance publication date 18 October 2007

International Classifications

C07D 311/80 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 47/06 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Organic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/305,021 10.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002319422

18 October 2007 Application Accepted

  Published as AU-B-2002319422

6 December 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 26 Oct 2007. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

21 February 2008 Standard Patent Sealed

1 May 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 26 Oct 2007

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319423-Biologically active peptides

2002319421-REMOVABLE DEVICE COVER